Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |